Use of non-steroidal anti-inflammatory drugs in pregnancy and oligohydramnios: a review.
Valentina D'AmbrosioFlaminia VenaAnnalisa ScopellitiDebora D'AnielloGiovanna SavastanoRoberto BrunelliAntonella GiancottiPublished in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2023)
The use of NSAIDs should be considered when maternal benefits outweigh the potential fetal risk, at the lowest effective dose for shortest duration. Beyond 48 h of NSAIDs treatment, we consider ultrasound monitoring of amniotic fluid, and we suggest stopping therapy if a decline AFI is present.